Premier Pharmacy Labs Inc. is recalling 12,917 units of various injectable medications, including Morphine Sulfate, Hydromorphone HCl, and Neostigmine Methylsulfate, packaged in sterile single-dose syringes. The recall was initiated because microbial contamination was detected in unreleased product lots, suggesting a potential failure in the sterility of the packaging system. If a non-sterile drug is injected into a patient, it can lead to serious and potentially life-threatening infections. These products were distributed nationwide in the United States and were manufactured at their Weeki Wachee, Florida facility.
A defect in the interaction between the product syringe and the tamper-evident container closure may allow microorganisms to enter the medication. Injecting a contaminated drug product directly into the body bypasses natural defenses and can cause severe systemic infections or sepsis.
Drug Recall Refund Guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.